U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 6 of 6 results

Status:
US Approved Rx (2017)
First approved in 1986

Class (Stereo):
CHEMICAL (ACHIRAL)



Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin. Tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmi...
Status:
US Approved Rx (2021)
First approved in 1964

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

6-Aminocaproic acid (epsilon-aminocaproic acid, marketed as Amicar) is an ant fibrinolytic agent that acts by inhibiting plasminogen activators, which have fibrinolytic properties. It is useful in enhancing hemostasis when fibrinolysis contributes to...
Status:
Other

Class (Stereo):
CHEMICAL (ACHIRAL)

Targets:

Conditions:

cis-Tranexamic acid blocks the plasminogen, and thus possesses antifibrinolytic properties.
Status:
US Approved Rx (2021)
First approved in 1964

Class (Stereo):
CHEMICAL (ACHIRAL)


Conditions:

6-Aminocaproic acid (epsilon-aminocaproic acid, marketed as Amicar) is an ant fibrinolytic agent that acts by inhibiting plasminogen activators, which have fibrinolytic properties. It is useful in enhancing hemostasis when fibrinolysis contributes to...